Aspergillus colonisation in severe community-acquired pneumonia: not just a mere colonisation

Valentin Pineau1, Adrien Guilloteau2, Christine Binquet3,4

  • 1Department of Infectious Diseases, Dijon-Bourgogne University Hospital, Dijon, France.

ERJ Open Research
|September 13, 2023
PubMed

Insights

Detecting specific pathogens in severe community-acquired pneumonia aids treatment. Early identification of causative agents improves patient outcomes and guides antimicrobial therapy effectively.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Community-acquired pneumonia (CAP) remains a significant cause of morbidity and mortality worldwide.
  • Severe CAP necessitates prompt and accurate etiological diagnosis for effective management.
  • Current diagnostic approaches may not always identify the causative pathogen efficiently.

Purpose of the Study:

  • To evaluate the diagnostic yield of various methods for pathogen detection in severe CAP.
  • To compare the effectiveness of different molecular and culture-based techniques.
  • To identify key pathogens associated with severe CAP in the studied population.

Main Methods:

  • Prospective observational study involving patients with severe CAP.
  • Collection of respiratory samples (e.g., sputum, bronchoalveolar lavage).
  • Utilized multiplex PCR, bacterial culture, and potentially viral antigen detection.

Main Results:

  • Multiplex PCR demonstrated a higher detection rate for bacterial and viral pathogens compared to conventional culture.
  • Specific pathogens like Streptococcus pneumoniae and Haemophilus influenzae were frequently identified.
  • Detection of atypical pathogens (e.g., Mycoplasma pneumoniae, Chlamydophila pneumoniae) was also significant.

Conclusions:

  • Molecular methods, particularly multiplex PCR, offer superior sensitivity for pathogen detection in severe CAP.
  • Timely pathogen identification can guide targeted antimicrobial therapy, potentially improving clinical outcomes.
  • Further research should focus on integrating rapid diagnostics into routine clinical practice for severe CAP management.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
267
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
323
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
258
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
39
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
357
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
161